Updates are available Correction dated 2025-03-19
Click to view Correction: https://doi.org/10.1186/s13045-025-01683-5
-
Authors
Berneman, Zwi N.
De Laere, Maxime
Germonpré, Paul
Huizing, Manon T.
Willemen, Yannick
Lion, Eva
De Reu, Hans
Van den Bossche, Jolien
Van den Brande, Jan
Specenier, Pol
Altintas, Sevilay
van Dam, Peter A.
Cools, Nathalie
Nijs, Griet
Stein, Barbara
Caluwaerts, Kim
Snoeckx, Annemiek
Op de Beeck, Bart
Saevels, Kirsten
Rutsaert, Lynn
Vandenbosch, Irma
Oner, Gizem
Lammens, Martin
Van Damme, Pierre
Llewellyn-Lacey, Sian
Price, David A.
Oka, Yoshihiro
Oji, Yusuke
Sugiyama, Haruo
Couttenye, Marie M.
Van de Velde, Ann L.
Van Tendeloo, Viggo F.
Peeters, Marc
Anguille, Sébastien
Smits, Evelien L.J.M.
-
Funding
Funding for this research was provided by:
Wellcome Trust Senior Investigator Award (100326Z/12/Z)
Fonds Wetenschappelijk Onderzoek (1806220N)
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 8 January 2025
First Online: 23 January 2025
Change Date: 19 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13045-025-01683-5
Declarations
:
: This study was approved by the Ethics Committee of the Antwerp University Hospital/University of Antwerp (EC 10/40/266) and the Belgian Federal Agency for Medicines and Health Products (FAGG 08 − 0005) and registered at ClinicalTrials.gov (NCT01291420) and EudraCT (2011-000547-24). The sponsor’s protocol code was CCRG 11 − 001. All participants provided informed written consent in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: VFVT and ZNB are coinventors of a now-elapsed patent covering the messenger RNA electroporation technique (Improved Transfection of Eukaryotic Cells with Linear Polynucleotides by Electroporation, WO/2003/000907).
